FIELD: chemistry.
SUBSTANCE: invention relates to 2-{4-amino-2-[(3-chloro-4-methoxy-5-methylpyridin-2-yl)methyl]-2,7-dihydro-6-thia-1,2,3,5-tetraazabenzo[cd]azulen-8-yl}-N-methylacetamide and its salts, such as hydrobromide, hydrochloride, methane sulfonate, ethane-1,2-disulfonate. The invention also relates to a medication and a pharmaceutical composition based on the said compound and its salts for inhibition of ATP-ase activity of HSP90.
EFFECT: novel compound and its salts, which can be applied in medicine for cancer treatment, are obtained.
23 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLOPYRIMIDINE DERIVATIVE | 2007 |
|
RU2420530C2 |
| NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
| NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
| VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
| BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
| NOVEL QUINOLINE-SUBSTITUTED COMPOUND | 2014 |
|
RU2689158C2 |
| NEW QUINOLINE-SUBSTITUTED COMPOUND | 2014 |
|
RU2797117C2 |
| QUINOLINE AND QUINAZOLINE DERIVATIVES | 2000 |
|
RU2256654C2 |
| INHIBITOR OF EGFR AND PRODUCTION AND USE THEREOF | 2015 |
|
RU2702631C2 |
| PYRIDYL KETONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATION THEREOF | 2014 |
|
RU2667892C2 |
